Medical Device News Magazine

Advancing Healthcare Energy: Olympus Awarded PROVISTA Contract

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Provista

Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the POWERSEAL™ sealer/divider, the SONICBEAT™ ultrasonic portfolio and THUNDERBEAT™ hybrid energy portfolio.

The multi-year agreement was effective as of July 1, 2023.

The Olympus advanced energy portfolio is available under this contract, including:

  • The Universal Surgical Energy Generator (EPF-1), which provides common forms of surgical energy and eliminates the need for multiple generators.
  • The SONICBEAT Ultrasonic Energy Portfolio, which offers precise dissection with 5mm sealing and secure tissue grasping thanks to unique wiper jaw design.1
  • The THUNDERBEAT Hybrid Energy Portfolio, which offers efficiency through fast cutting and versatility and 7mm sealing and precise dissection.2
  • The POWERSEAL Sealer/Divider, which features a curved, tapered and double-action Maryland dissector/grasper design and vessel sealing up to and including 7mm, including pulmonary vessels, tissue bundles and lymphatics.3

Jay Sullivan, Group Vice President, Enterprise Solutions, Medical Systems Group, Olympus

“Contract awards are important to our business. But even more important is that the Provista awards create opportunities for customers such as ASCs to access state-of-the-art equipment toward improving patient care in a value-based framework. The ASC market is important for healthcare providers and the communities they serve, and we are focused on growing our presence there.”

Energy Options Offered Through Olympus

Olympus offers an array of energy options such as the THUNDERBEAT hybrid energy devices portfolio that deliver ultrasonic and bipolar energy simultaneously for tissue management, including hemostatic cutting and dissection, in laparoscopic surgery and open surgery. Olympus’ POWERSEAL devices can be used in general surgery and gynecological, colorectal, bariatric, urological, thoracic and vascular surgical procedures.

EPF-1 Generator

The EPF-1 generator, with its accessories and ancillary equipment, is intended for cutting and coagulation of tissue in open, laparoscopic and endoscopic surgery and should only be used by a qualified physician in an adequate medical environment.  Improper use or use of incompatible equipment with these generators may lead to excessive or incorrect HF and cause thermal or other injuries for the patient and/or operator.

All plugs must be securely inserted into the corresponding sockets for proper use. Be aware that if the main plug is accidentally disconnected during a procedure, the electrosurgical generator immediately turns off and this may result in complications for the patient should it occur during energy delivery. Please refer to the instructions for use prior to usage.

References

1 Data on file with Olympus (869-2368, 869-2512)
2 Data on file with Olympus (868-4375, 868-4378, 868-3710)
3 Data on file with Olympus (DN004705, DN0044706)

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”